We are live on ! Find out more
PAWC

P.A.W. Capital Portfolio holdings

AUM $131M
1-Year Est. Return 46.14%
This Fund
S&P 500
This Quarter Est. Return
+14.54%
1 Year Est. Return
+46.14%
3 Year Est. Return
+67.18%
5 Year Est. Return
+64.85%
10 Year Est. Return
+1,459.33%
AUM
$114M
AUM Growth
+$299K
Cap. Flow
-$13.9M
Cap. Flow %
-12.27%
Top 10 Hldgs %
45.93%
Holding
70
New
9
Increased
15
Reduced
23
Closed
5

Top Buys

Rank Stock Value
1
RTB
RTB Digital
RTB
+$1.88M
2
QURE icon
uniQure
QURE
+$1.08M
3
ENVX icon
Enovix
ENVX
+$1.05M
4
TFFP
TFF Pharmaceuticals, Inc. Common Stock
TFFP
+$1.04M
5
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$911K

Top Sells

Rank Stock Value
1
MGNI icon
Magnite
MGNI
+$6.5M
2
APPS icon
Digital Turbine
APPS
+$3.65M
3
OPRX icon
OptimizeRx
OPRX
+$2.89M
4
RGNX icon
Regenxbio
RGNX
+$1.81M
5
MITK icon
Mitek Systems
MITK
+$1.78M

Sector Composition

Rank Sector Weight
1 Technology 32.42%
2 Healthcare 19.4%
3 Communication Services 18.6%
4 Consumer Staples 6.82%
5 Industrials 6.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QURE icon
26
uniQure
QURE
$3.03B
$1.01M 0.89%
+30,000
New +$1.08M
ENVX icon
27
Enovix
ENVX
$892M
$932K 0.82%
+80,000
New +$1.05M
ISEE
28
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$927K 0.82%
+150,000
New +$911K
CSCO icon
29
Cisco
CSCO
$457B
$879K 0.77%
17,000
– –
TFFP
30
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
$864K 0.76%
+2,548
New +$1.04M
JPM icon
31
JPMorgan Chase
JPM
$935B
$837K 0.74%
5,500
-500
-8% -$71.9K
DOW icon
32
Dow Inc
DOW
$21.9B
$831K 0.73%
13,000
-500
-4% -$29.9K
TCPC icon
33
BlackRock TCP Capital
TCPC
$273M
$830K 0.73%
60,000
– –
JNJ icon
34
Johnson & Johnson
JNJ
$618B
$822K 0.72%
5,000
– –
MO icon
35
Altria Group
MO
$114B
$819K 0.72%
16,000
– –
VZ icon
36
Verizon
VZ
$195B
$814K 0.72%
14,000
+2,000
+17% +$113K
PG icon
37
Procter & Gamble
PG
$336B
$813K 0.72%
6,000
+1,000
+20% +$130K
MRK icon
38
Merck
MRK
$322B
$809K 0.71%
11,004
+1,572
+17% +$116K
KHC icon
39
Kraft Heinz
KHC
$30.7B
$800K 0.7%
20,000
– –
PM icon
40
Philip Morris
PM
$297B
$799K 0.7%
9,000
– –
PFE icon
41
Pfizer
PFE
$143B
$797K 0.7%
22,000
+4,000
+22% +$142K
CVX icon
42
Chevron
CVX
$392B
$786K 0.69%
7,500
-500
-6% -$48.8K
GS icon
43
Goldman Sachs
GS
$300B
$785K 0.69%
2,400
-600
-20% -$187K
XOM icon
44
ExxonMobil
XOM
$644B
$782K 0.69%
14,000
-4,000
-22% -$210K
PEP icon
45
PepsiCo
PEP
$190B
$778K 0.68%
5,500
+500
+10% +$68.6K
MS icon
46
Morgan Stanley
MS
$331B
$777K 0.68%
10,000
-1,000
-9% -$76.6K
MMM icon
47
3M
MMM
$90.9B
$771K 0.68%
4,784
– –
ABBV icon
48
AbbVie
ABBV
$443B
$758K 0.67%
7,000
– –
T icon
49
AT&T
T
$159B
$757K 0.67%
33,100
+2,648
+9% +$58.5K
ARCC icon
50
Ares Capital
ARCC
$13.5B
$748K 0.66%
40,000
– –
1
2
3

Similar funds

EIM
Emmett Investment Management New York $131M AUM 25.7% 1-Year Est. Return
CIP
Castlefield Investment Partners Manchester $131M AUM
AC
Aldebaran Capital Carmel, Indiana $131M AUM 34.7% 1-Year Est. Return
ADEF
ABS Direct Equity Fund Stamford, Connecticut $131M AUM 7.53% 1-Year Est. Return
LC
LTG Capital Newton, Massachusetts $131M AUM 19.7% 1-Year Est. Return
EWP
Evergreen Wealth Partners Kalispell, Montana $131M AUM
OIM
Oder Investment Management Woodland Hills, California $130M AUM 25.54% 1-Year Est. Return
EPI
Eddie Patel Inc Chicago, Illinois $130M AUM

P.A.W. Capital's Q1 2021 Portfolio in Review

As of Q1 2021, P.A.W. Capital held 70 positions worth $114M, up 0.26% from $113M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

P.A.W. Capital withdrew a net $13.9M in Q1 2021, closing 5 positions and reducing 23 holdings. Its most notable exit was Regenxbio, an estimated $1.81M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 32% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, P.A.W. Capital opened a new position in RTB Digital worth $2.1M.

  • P.A.W. Capital's largest Q1 2021 buy was RTB Digital: 429 shares worth $2.1M.
  • P.A.W. Capital added most to Zix Corporation in Q1 2021, an estimated $842K increase.
  • P.A.W. Capital's biggest Q1 2021 reduction was Magnite, cutting an estimated $6.5M.
  • P.A.W. Capital fully exited Regenxbio in Q1 2021, selling an estimated $1.81M.
  • P.A.W. Capital's ten largest holdings make up 46% of its $114M portfolio in Q1 2021.
  • P.A.W. Capital opened 9 new positions and closed 5 in Q1 2021.
  • P.A.W. Capital's portfolio value rose 0.26% quarter-over-quarter to $114M.

Based on P.A.W. Capital's 13F filing for Q1 2021, filed 10 May 2021.